Spero Therapeutics, Inc. (SPRO) Shareholders’ equity 2016–2025
Spero Therapeutics, Inc. (SPRO) shareholders’ equity at each fiscal year-end, per SEC filings.
$59.0MFY2025 · since FY2016: -$45.4M → $59.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $59.0M | +28.0% |
| FY2024 | $46.1M | -56.9% |
| FY2023 | $106.9M | +40.8% |
| FY2022 | $75.9M | -14.0% |
| FY2021 | $88.3M | -33.1% |
| FY2020 | $132.0M | +77.1% |
| FY2019 | $74.6M | -35.4% |
| FY2018 | $115.5M | +36.5% |
| FY2017 | $84.6M | +286.2% |
| FY2016 | -$45.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice